ID
13261
Description
Prospective,multicentric,double blind and placebo-controlled Phase III clinical trial to determine efficacy and tolerability of subcutaneous hyposensitization with CLUSTOID in patients with allergic rhinoconjunctivits caused by grass or rye pollen. EudraCT-Nr. 2008-000513-29 Study-code:CLU-2008-001 Sponsor: ROXALL Medizin GmbH Carl-Petersen-Straße 4 20535 Hamburg Phone:040-8972520 Fax:040-89725223 Project coordinator: Dr.Jenny Uhlig ROXALL Medizin GmbH Head of clinical investigation: Prof.Dr.med.Ludger Klimek An den Quellen 10 65183 Wiesbaden Phone:0611-8904381 Fax:0611-3082360 Monitoring,data management and statistical evaluation: IMSIE- Institut for medical statistics,computer sciences and epidemiology University hospital Cologne Lindenburger Allee 42 50931 Cologne Phone:0221-4783456 Fax:0221-4783465
Mots-clés
Versions (1)
- 27/01/2016 27/01/2016 -
Téléchargé le
27 janvier 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Efficacy and tolerability of subcutaneous hyposensitization with CLUSTOID in Patients with allergic rhinoconjunctivitis SAE report form
Serious Adverse Event report form
- StudyEvent: ODM
Description
Observed SAE
Description
Date of occurrence
Type de données
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C2697887
Description
Description of SAE
Type de données
text
Alias
- UMLS CUI [1,1]
- C0678257
- UMLS CUI [1,2]
- C1519255
Description
Opinion of investigator
Description
Medication
Type de données
text
Alias
- UMLS CUI [1]
- C0013227
Description
Daily dose
Type de données
float
Alias
- UMLS CUI [1]
- C2348070
Description
Drug application route
Type de données
text
Alias
- UMLS CUI [1]
- C0013153
Description
Medication use start date
Type de données
date
Alias
- UMLS CUI [1,1]
- C0240320
- UMLS CUI [1,2]
- C0808070
Description
Medication use end date
Type de données
date
Alias
- UMLS CUI [1,1]
- C0240320
- UMLS CUI [1,2]
- C0806020
Description
SAE Context
Type de données
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0041755
Description
Outcome and treatment
Description
Lifethreatening
Type de données
boolean
Alias
- UMLS CUI [1]
- C1517874
Description
Hospitalization
Type de données
boolean
Alias
- UMLS CUI [1]
- C0019993
Description
Date of hospital admission
Type de données
date
Alias
- UMLS CUI [1]
- C0806429
Description
Treatment methods
Type de données
text
Alias
- UMLS CUI [1]
- C0679624
Description
Attached documents
Type de données
text
Alias
- UMLS CUI [1]
- C1999228
Description
Patient outcome
Type de données
text
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C1519255
Description
Death Related to Adverse Event
Type de données
boolean
Alias
- UMLS CUI [1]
- C1705232
Description
Death context to trial substance
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C2983596
- UMLS CUI [1,2]
- C0041755
Description
Date
Type de données
date
Alias
- UMLS CUI [1]
- C0011008
Description
Signature
Type de données
text
Alias
- UMLS CUI [1]
- C1519316
Similar models
Serious Adverse Event report form
- StudyEvent: ODM
C2697887 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0041755 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,2])
C0041755 (UMLS CUI [1,2])